(Q33797156)

29 July 2017

1 reference

title

Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway (English)

1 reference

29 July 2017

0 references

Epinat JC

1

1 reference

29 July 2017

Gilmore TD

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

6896-6909

1 reference

29 July 2017

49

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203218

29 July 2017

0 references

cites work

Phenylarsine oxide inhibits ex vivo HIV-1 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The NF-kappaB/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Control of apoptosis by Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

IkappaBalpha degradation and nuclear factor-kappaB DNA binding are insufficient for interleukin-1beta and tumor necrosis factor-alpha-induced kappaB-dependent transcription. Requirement for an additional activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Hypericin as a non-antioxidant inhibitor of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of nuclear factor kappaB by direct modification in whole cells--mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappaB activity results in disruption of the apical ectodermal ridge and aberrant limb morphogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

TRAF6 is a signal transducer for interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Prostaglandins prevent inducible nitric oxide synthase protein expression by inhibiting nuclear factor-kappaB activation in J774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of nuclear factor kappaB by sulfasalazine: a new target for inflammatory bowel disease therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

IL-10 down-regulates human microglial IL-8 by inhibition of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Lactacystin, proteasome function, and cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

HOS, a human homolog of Slimb, forms an SCF complex with Skp1 and Cullin1 and targets the phosphorylation-dependent degradation of IkappaB and beta-catenin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappaB-dependent transcription of human immunodeficiency virus 1 promoter by a phosphodiester compound of vitamin C and vitamin E, EPC-K1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

MEK kinase is involved in tumor necrosis factor alpha-induced NF-kappaB activation and degradation of IkappaB-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Herbimycin A blocks IL-1-induced NF-kappa B DNA-binding activity in lymphoid cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

JNK or IKK, AP-1 or NF-kappaB, which are the targets for MEK kinase 1 action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Serotonin derivative, N-(p-coumaroyl) serotonin, inhibits the production of TNF-alpha, IL-1alpha, IL-1beta, and IL-6 by endotoxin-stimulated human blood monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Suppression of NF kappa B activation and NF kappa B-dependent gene expression by tepoxalin, a dual inhibitor of cyclooxygenase and 5-lipoxygenase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Pyrithione, a zinc ionophore, inhibits NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

MEKK1 activates both IkappaB kinase alpha and IkappaB kinase beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

NF-kappaB-inducing kinase activates IKK-alpha by phosphorylation of Ser-176

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Studies into the effect of the tyrosine kinase inhibitor herbimycin A on NF-kappa B activation in T lymphocytes. Evidence for covalent modification of the p50 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Interleukin-4 down-regulates both forms of tumor necrosis factor receptor and receptor-mediated apoptosis, NF-kappaB, AP-1, and c-Jun N-terminal kinase. Comparison with interleukin-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappaB DNA binding by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Protein tyrosine kinase inhibitors block tumor necrosis factor-induced activation of nuclear factor-kappaB, degradation of IkappaBalpha, nuclear translocation of p65, and subsequent gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Coordinate regulation of IkappaB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-kappaB-inducing kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of the mitogen-activated protein kinase kinase superfamily by a Yersinia effector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Hydroquinone, a reactive metabolite of benzene, inhibits NF-kappa B in primary human CD4+ T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Phosphatidylinositol 3-kinase in interleukin 1 signaling. Physical interaction with the interleukin 1 receptor and requirement in NFkappaB and AP-1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Identification and characterization of an IkappaB kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Activation of the heat shock factor 1 by serine protease inhibitors. An effect associated with nuclear factor-kappaB inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Selective inhibition of NF-kappaB activation by the flavonoid hepatoprotector silymarin in HepG2. Evidence for different activating pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Iron chelation decreases NF-kappa B and HIV type 1 activation due to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The yopJ locus is required for Yersinia-mediated inhibition of NF-kappaB activation and cytokine expression: YopJ contains a eukaryotic SH2-like domain that is essential for its repressive activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappa B activation in human T-cell lines by anetholdithiolthione

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Involvement of intracellular Ca2+ in oxidant-induced NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

A positively charged alpha-lipoic acid analogue with increased cellular uptake and more potent immunomodulatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

An allosteric drug, o,o'-bismyristoyl thiamine disulfide, suppresses HIV-1 replication through prevention of nuclear translocation of both HIV-1 Tat and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Structure, regulation and function of NF-kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Activation of nuclear factor kappaB by nitric oxide in rat striatal neurones: differential inhibition of the p50 and p65 subunits by dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Protein-tyrosine phosphatase inhibitors block tumor necrosis factor-dependent activation of the nuclear transcription factor NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Antioxidants inhibit stimulation of HIV transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappa B activation by vitamin E derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

c-Rel is a target of pentoxifylline-mediated inhibition of T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

21 January 2018

The actions of NSAIDs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

I kappa B proteins: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Sulindac inhibits activation of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Glutathione downregulates the phosphorylation of I kappa B: autoloop regulation of the NF-kappa B-mediated expression of NF-kappa B subunits by TNF-alpha in mouse vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Lacidipine inhibits the activation of the transcription factor NF-kappaB and the expression of adhesion molecules induced by pro-oxidant signals on endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF-kappa B.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

The effect of sodium salicylate and aspirin on NF-kappa B

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Cycloepoxydon, 1-hydroxy-2-hydroxymethyl-3-pent-1-enylbenzene and 1-hydroxy-2-hydroxymethyl-3-pent-1,3-dienylbenzene, new inhibitors of eukaryotic signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the degradation of I kappa B-alpha and I kappa B-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Potent inhibitors of proteasome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Nuclear factor kappa B activity in response to oxidants and antioxidants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Inhibition of tumor necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Interleukin 1 beta-induced expression of nitric oxide synthase in rat renal mesangial cells is suppressed by cyclosporin A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Pyrrolidine dithiocarbamate protects mice from lethal shock induced by LPS or TNF-α

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Is NF-kappaB the sensor of oxidative stress?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Dimethyldithiocarbamate inhibits in vitro activation of primary human CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Cytokine-modulating activity of tepoxalin, a new potential antirheumatic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Site-specific tyrosine phosphorylation of IkappaBalpha negatively regulates its inducible phosphorylation and degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Nicotine inhibits the production of inflammatory mediators in U937 cells through modulation of nuclear factor-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Estrogen inhibits phorbol ester-induced I kappa B alpha transcription and protein degradation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Interleukin-11. A gp130 cytokine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Inhibitory effect of glycyrrhizin on NF-kappaB binding activity in CCl4- plus ethanol-induced liver cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Inhibition of the DNA-binding activity of NF-kappa B by gold compounds in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203218

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203218

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference